Market Insights
"The global fibrinogen concentrate market size was estimated at USD 2.79 billion in 2021 and is likely to grow at a CAGR of 5.53% during 2022-2028 to reach USD 4.09 billion by 2028."

Wish to get a free sample? Click Here.
Fibrinogen concentrate is defined as a blood coagulation factor used in the treatment of acute bleeding episodes in patients who have congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia. Fibrinogen concentrate can be categorized as human fibrinogen concentrates and animal fibrinogen concentrates.
Fibrinogen Concentrate Market Report Overview
|
Market Size in 2028
|
USD 4.09 Billion
|
Market Size in 2021
|
USD 2.79 Billion
|
Market Growth (2022-2028)
|
CAGR of 5.53%
|
Base Year of Study
|
2021
|
Trend Period
|
2016-2020
|
Forecast Period
|
2022-2028
|
Market Dynamics
Market Drivers
The growth of the market is primarily driven by:
- Rising incidences of blood related disorders due to stress and changing lifestyle.
- Increasing use of fibrinogen concentrate to treat congenital deficiencies is likely to propel the global fibrinogen concentrate market progress at a significant rate during the review period.
- In addition to this, increasing investment in research and development activities is likely to create lucrative opportunities for the players operating in the global market in the coming years.
Latest Trends
The fibrinogen concentrate market is expected to experience significant growth due to the increasing prevalence of hemophilia and advancements in fibrinogen-related products. With more than 350,000 hemophilia cases and more than 70% of affected individuals not receiving proper treatment, the market is expected to grow.
A 2019 review by the Journal of Apoplexy and Haemostasis, Fibclot and Clottafact found that human fibrinogen concentrate is effective in treating patients with fibrinogen deficiency. The increasing prevalence of hemophilia and the safety and efficacy of human fibrinogen concentrate are expected to drive market development in this area.
Restraining Factors
Fibrinogen concentrate can cause side effects like chills, fever, sickness, and heaving, which can be severe. Adverse effects include anaphylactic reactions, which can be a sensitivity side effect or first signs of touchiness. If these reactions occur, it is crucial to stop using the drug immediately.
In patients with inborn fibrinogen deficiency, apoplexy can occur both with and without fibrinogen substitution treatment. Patients receiving fibrinogen concentrate may also experience pneumonic embolism, myocardial localized necrosis, deep vein apoplexy, and blood vessel apoplexy signs and side effects.
COVID-19 Impact
The Covid-19 outbreak posed significant challenges on the healthcare sector across geographies. It impacted the progress of the market negatively as only essential and emergency healthcare services were being provided in the hospitals and thus, affected the market progress for a short period of time.
Segments Analysis
Segmentations
|
List of Sub-Segments
|
Dominant and Fastest-Growing Segments
|
Type Analysis
|
Human Fibrinogen Concentrates, Animal Fibrinogen Concentrates
|
The forecasted period's largest segment share is expected to be human fibrinogen concentrate.
|
Application Analysis
|
Hospitals, Ambulatory Surgical Centers, Others
|
The hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the forecast period.
|
Regional Analysis
|
North America, Europe, Asia-Pacific, Middle East and Africa, and South America
|
North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period.
|
By Type
"The human fibrinogen concentrates segment accounted for the largest market share."
The market has been bifurcated into human fibrinogen concentrates, animal fibrinogen concentrates. The forecasted period's largest segment share is expected to be human fibrinogen concentrate, driven by the growing demand for fibrinogen concentrate for treating bleeding disorders and congenital coagulation deficiencies.
Application Trends
"The hospitals segment accounted for the largest market share."
The market has been bifurcated into hospitals, ambulatory surgical centers and others. Under these, the hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period on account of presence of established healthcare infrastructure and professional healthcare staff.
Regional Insights
"North America accounted for the largest market share."
The market in North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to increasing incidences of blood related disorders and presence of key market players such as Thermo Fisher Scientific (The U.S) and Cayman Chemical Company (The U.S). The market progress in Asia-Pacific region is expected to be driven by increasing use of fibrinogen concentrate in treating congenital deficiencies.

To know high-growth countries in this report, Register Here.
Key Players
The following are the key players in the fibrinogen concentrate market (arranged alphabetically).
- Affinity Biologicals Inc (Canada),
- AkronBiotech (The U.S),
- Bovogen Biologicals Pty Ltd. (Australia),
- Cayman Chemical Company (The U.S),
- CSL Limited (Australia),
- Enzo Life Sciences, Inc. (The U.S),
- Green Cross Corporation (South Korea),
- Molecular Innovations (The U.S),
- Octapharma AG (Switzerland),
- The LFB group (France),
- The Merck Group (Germany) and
- Thermo Fisher Scientific (The U.S).
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Report Features
This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players as well as those willing to enter the fibrinogen concentrate market.
What Deliverables Will You Get in this Report?
Key questions this report answers
|
Relevant contents in the report
|
How big is the sales opportunity?
|
In-depth analysis of the Fibrinogen Concentrate Market
|
How lucrative is the future?
|
The market forecast and trend data and emerging trends
|
Which regions offer the best sales opportunities?
|
Global, regional and country-level historical data and forecasts
|
Which are the most attractive market segments?
|
Market segment analysis and Forecast
|
Which are the top players and their market positioning?
|
Competitive landscape and Market share analysis
|
How complex is the business environment?
|
Porter’s five forces, PEST and Life cycle analysis
|
What are the factors affecting the market?
|
Drivers & challenges
|
Will I get the information on my specific requirement?
|
10% free customization
|
Research Methodology
This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s fibrinogen concentrate market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Customization Options
Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
- Detailed profiling of additional market players (up to 3 players).
- SWOT analysis of key players (up to 3 players).
Competitive Benchmarking
- Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.